Related Experiment Video
Updated: Jan 24, 2026

The Microscopy-Based Assay to Study and Analyze the Recycling Endosomes using SNARE Trafficking
Published on: February 12, 2022
SORLA regulates endosomal trafficking and oncogenic fitness of HER2
Mika Pietilä1, Pranshu Sahgal2, Emilia Peuhu2
1Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland. mika.pietila@utu.fi.
Abstract:
The human epidermal growth factor receptor 2 (HER2) is an oncogene targeted by several kinase inhibitors and therapeutic antibodies. While the endosomal trafficking of many other receptor tyrosine kinases is known to regulate their oncogenic signalling, the prevailing view on HER2 is that this receptor is predominantly retained on the cell surface. Here, we find that sortilin-related receptor 1 (SORLA; SORL1) co-precipitates with HER2 in cancer cells and regulates HER2 subcellular distribution by promoting recycling of the endosomal receptor back to the plasma membrane. SORLA protein levels in cancer cell lines and bladder cancers correlates with HER2 levels. Depletion of SORLA triggers HER2 targeting to late endosomal/lysosomal compartments and impairs HER2-driven signalling and in vivo tumour growth. SORLA silencing also disrupts normal lysosome function and sensitizes anti-HER2 therapy sensitive and resistant cancer cells to lysosome-targeting cationic amphiphilic drugs. These findings reveal potentially important SORLA-dependent endosomal trafficking-linked vulnerabilities in HER2-driven cancers.
Insights
Sortilin-related receptor 1 (SORLA) regulates human epidermal growth factor receptor 2 (HER2) trafficking in cancer cells. SORLA depletion impairs HER2 signaling and tumor growth, revealing new therapeutic vulnerabilities.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Human epidermal growth factor receptor 2 (HER2) is a key oncogene in various cancers.
- HER2 signaling is regulated by its subcellular localization and endosomal trafficking.
- The role of endosomal trafficking in HER2 regulation is not fully understood, with a prevailing view of cell surface retention.
Purpose of the Study:
- To investigate the role of sortilin-related receptor 1 (SORLA) in HER2 trafficking and signaling.
- To determine the impact of SORLA on HER2-driven tumor growth and response to therapy.
Main Methods:
- Co-immunoprecipitation assays to assess SORLA-HER2 interaction.
- Analysis of HER2 subcellular distribution upon SORLA modulation.
- Assessment of HER2 signaling pathways and in vivo tumor growth in SORLA-depleted models.
- Evaluation of lysosome function and drug sensitivity after SORLA silencing.
Main Results:
- SORLA co-precipitates with HER2 and promotes its recycling to the plasma membrane.
- SORLA levels correlate with HER2 levels in cancer cell lines and bladder cancers.
- SORLA depletion leads to HER2 lysosomal degradation, impaired signaling, and reduced tumor growth.
- SORLA silencing disrupts lysosome function and sensitizes cancer cells to lysosome-targeting drugs.
Conclusions:
- SORLA plays a critical role in regulating HER2 subcellular distribution and signaling.
- SORLA-dependent endosomal trafficking represents a potential vulnerability in HER2-driven cancers.
- Targeting SORLA or related pathways may offer novel therapeutic strategies for HER2-positive cancers.
Related Concept Videos
Maturation of Endosomes
Changes in location
The maturing endosome moves along microtubules from the periphery of the cell towards the perinuclear region. This movement of the...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Inclusive Fitness
The Early Endosome: Endocytosis of Transferrin
Recycling Endosomes and Transcytosis
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
Goodness-of-Fit Test

